Nuveen Asset Management, LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,420,394
-12.8%
164,588
+4.6%
0.00%0.0%
Q2 2023$1,628,355
+96999.3%
157,329
+1.8%
0.00%0.0%
Q1 2023$1,677
-40.7%
154,510
-38.7%
0.00%0.0%
Q4 2022$2,828
-99.8%
252,047
+43.1%
0.00%0.0%
Q3 2022$1,787,000
-17.9%
176,173
-26.6%
0.00%0.0%
Q2 2022$2,176,000
+20.2%
240,162
+28.5%
0.00%0.0%
Q1 2022$1,811,000
+9.7%
186,906
+13.4%
0.00%
Q4 2021$1,651,000
+31.4%
164,790
-6.7%
0.00%
Q3 2021$1,256,000
-53.9%
176,717
-5.8%
0.00%
-100.0%
Q2 2021$2,725,000
-30.4%
187,672
-2.2%
0.00%0.0%
Q1 2021$3,916,000
+15.9%
191,887
+0.9%
0.00%0.0%
Q4 2020$3,379,000
+9.0%
190,160
-9.3%
0.00%0.0%
Q3 2020$3,099,000
-31.5%
209,633
-2.8%
0.00%
-50.0%
Q2 2020$4,526,000
-35.2%
215,653
-28.6%
0.00%
-33.3%
Q1 2020$6,982,000
-0.8%
302,145
+11.1%
0.00%0.0%
Q4 2019$7,040,000
+30.1%
271,951
-2.1%
0.00%
+50.0%
Q3 2019$5,411,000
+49.9%
277,791
+25.6%
0.00%
+100.0%
Q2 2019$3,610,000221,0920.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$60,515,5108.59%
Irenic Capital Management LP 2,760,948$23,826,9816.76%
Newtyn Management, LLC 1,841,560$15,892,6633.92%
Weiss Asset Management LP 7,457,060$64,354,4283.81%
Park West Asset Management LLC 1,983,251$17,115,4561.57%
Baupost Group 7,419,226$64,0281.23%
Oasis Management Co Ltd. 953,254$8,226,5820.36%
Chescapmanager LLC 287,333$2,479,6840.32%
GSA CAPITAL PARTNERS LLP 325,985$2,8130.24%
Virtus ETF Advisers LLC 29,232$252,2720.15%
View complete list of THERAVANCE BIOPHARMA INC shareholders